The Jackson Laboratory collaborates to help the NIH fight rare diseases

Independent nonprofit biomedical research institute The Jackson Laboratory (JAX) has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the National Institute of Health’s National Center for the Advancement of Translational Sciences, for the purposes of creating new animal models and performing pharmacology studies to better understand and study diseases or treatments, especially for rare and neglected diseases.  The combined capabilities of the team members represent some of the best talents in the world to help the NIH in creating or characterizing novel disease models to address unmet needs.  Diseases such as sickle cell disease or other ailments have been difficult to fight without proper animal model resources, indicates Dr. Jake McDonald, Principal Investigator of the overall contract. Read more

Related Posts

Bangor will be abuzz with Maine science at annual festival

The Maine Science Festival’s headlining event will be a major collaboration with a local arts organization for the second year in...

23 March 2023

Report: National Institutes of Health added $264M to Maine economy in 2022

The National Institutes of Health supported 1,950 jobs and $264 million in economic activity in Maine during 2022 through $112.7 million in grants and...

22 March 2023

Northern Light completes deal to outsource diagnostics to Quest

Quest Diagnostics (NYSE: DGX), a Secaucus, N.J.-based diagnostic information services provider with a national footprint, said Monday that it has completed the acquisition...

21 March 2023